Literature DB >> 12812916

Rat kidney MAP17 induces cotransport of Na-mannose and Na-glucose in Xenopus laevis oocytes.

Tatiana Blasco1, José J Aramayona, Ana I Alcalde, Julia Catalán, Manuel Sarasa, Victor Sorribas.   

Abstract

Renal reabsorption is the main mechanism that controls mannose homeostasis. This takes place through a specific Na-coupled uphill transport system, the molecular identity of which is unknown. We prepared and screened a size-selected rat kidney cortex cDNA library through the expression of mannose transport in Xenopus laevis oocytes. We have identified a membrane protein that induces high-affinity and specific Na-dependent transport of d-mannose and d-glucose in X. laevis oocytes, most likely through stimulation of the capacity of an endogenous transport system of the oocyte. Sequencing has revealed that the cDNA encodes the counterpart of the human membrane-associated protein MAP17, previously known by its overexpression in renal, colon, lung, and breast carcinomas. We show that MAP17 is a 12.2-kDa nonglycosylated membrane protein that locates to the brush-border plasma membrane and the Golgi apparatus of transfected cells and that it is expressed in the proximal tubules of the kidney cortex and in the spermatids of the seminiferous tubules. It spans twice the cell membrane, with both termini inside the cell, and seems to form homodimers through intracellular Cys55, a residue also involved in transport expression. MAP17 is responsible for mannose transport expression in oocytes by rat kidney cortex mRNA. The induced transport has the functional characteristics of a Na-glucose cotransporter (SGLT), because d-glucose and alpha-methyl-d-glucopyranoside are also accepted substrates that are inhibited by phloridzin. The corresponding transporter from the proximal tubule remains to be identified, but it is different from the known mammalian SGLT-1, -2, and -3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812916     DOI: 10.1152/ajprenal.00149.2003

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  14 in total

1.  Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system.

Authors:  Serge M Gisler; Saranya Kittanakom; Daniel Fuster; Victoria Wong; Mia Bertic; Tamara Radanovic; Randy A Hall; Heini Murer; Jürg Biber; Daniel Markovich; Orson W Moe; Igor Stagljar
Journal:  Mol Cell Proteomics       Date:  2008-04-11       Impact factor: 5.911

2.  PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-β (TGF-β) signaling.

Authors:  Souichi Ikeno; Naoko Nakano; Keigo Sano; Takashi Minowa; Wataru Sato; Ryosuke Akatsu; Nobuo Sakata; Nobutaka Hanagata; Makiko Fujii; Fumiko Itoh; Susumu Itoh
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

3.  MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2.

Authors:  Michael J Coady; Abdulah El Tarazi; René Santer; Pierre Bissonnette; Louis J Sasseville; Joaquim Calado; Yoann Lussier; Christopher Dumayne; Daniel G Bichet; Jean-Yves Lapointe
Journal:  J Am Soc Nephrol       Date:  2016-06-10       Impact factor: 10.121

4.  Interactions of the growth-related, type IIc renal sodium/phosphate cotransporter with PDZ proteins.

Authors:  R Villa-Bellosta; M Barac-Nieto; S Y Breusegem; N P Barry; M Levi; V Sorribas
Journal:  Kidney Int       Date:  2007-11-28       Impact factor: 10.612

5.  MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival.

Authors:  Marco Perez; Juan M Praena-Fernandez; Blanca Felipe-Abrio; Maria A Lopez-Garcia; Antonio Lucena-Cacace; Angel Garcia; Matilde Lleonart; Guiovanna Roncador; Juan J Marin; Amancio Carnero
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

6.  MAP17, a ROS-dependent oncogene.

Authors:  Amancio Carnero
Journal:  Front Oncol       Date:  2012-09-06       Impact factor: 6.244

7.  The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.

Authors:  José M García-Heredia; Amancio Carnero
Journal:  Oncotarget       Date:  2017-10-06

Review 8.  Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.

Authors:  José M García-Heredia; Amancio Carnero
Journal:  Mol Cancer       Date:  2018-04-12       Impact factor: 27.401

9.  Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).

Authors:  Marco Perez; Javier Peinado-Serrano; Jose Manuel Garcia-Heredia; Irene Felipe-Abrio; Cristina Tous; Irene Ferrer; Javier Martin-Broto; Carmen Saez; Amancio Carnero
Journal:  Oncotarget       Date:  2016-10-11

10.  Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma.

Authors:  Xinhuang Chen; Yan Liao; Yaqun Yu; Pengpeng Zhu; Jun Li; Liling Qin; Weijia Liao; Zhaoquan Huang
Journal:  Oncotarget       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.